ELDERLY PATIENTS >65YEARS OF AGE WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME GAIN LIFE TIME FROM TREATMENT WITH TUMOR TREATING FIELDS AND TEMOZOLOMIDE

被引：0
|
作者：
Guzauskas, G. F. [1 ]
Wang, B. C. M. [1 ]
Kinzel, A. [2 ]
Proescholdt, C. [3 ]
机构：
[1] Univ Washington, Dept Pharm, Seattle, WA 98195 USA
[2] Novocure, Munich, Germany
[3] Novocure, Root, Switzerland
来源：
NEURO-ONCOLOGY | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P01.110
引用
收藏
页码：256 / 257
页数：2
相关论文
共 50 条
  • [41] Safety and efficacy of tumor treating fields (TTFields) prior and concomitant to radiotherapy in patients with newly diagnosed glioblastoma: Results from PriCoTTF
    Kebir, Seid
    Lazaridis, Lazaros
    Schmidt, Teresa
    Oster, Christoph
    Proescholdt, Martin
    Hau, Peter
    Grosu, Anca L.
    Krex, Dietmar
    Sure, Ulrich
    Scheffler, Bjoern
    Kleinschnitz, Christoph
    Ttgen, Christoph Po Spacing Diaeresis
    Stuschke, Martin
    Glas, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [42] Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial
    Chae-Yong Kim
    Sun Ha Paek
    Do-hyun Nam
    Jong-Hee Chang
    Yong-Kil Hong
    Jeong Hoon Kim
    Oh Lyong Kim
    Se-Hyuk Kim
    Journal of Neuro-Oncology, 2020, 146 : 399 - 406
  • [43] <bold> COMBINATION OF TUMOR TREATING FIELDS </bold>(TTFIELDS) WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) PATIENTS - A BI-CENTRIC ANALYSIS
    Lazaridis, Lazaros
    Schaefer, Niklas
    Schmidt, Teresa
    Weller, Johannes
    Tzaridis, Theophilos-Dimitrios
    Scheffler, Bjoern
    Pierscianek, Daniela
    Kleinschnitz, Christoph
    Stuschke, Martin
    Sure, Ulrich
    Herrlinger, Ulrich
    Kebir, Sied
    Glas, Martin
    NEURO-ONCOLOGY, 2019, 21 : 229 - 230
  • [44] Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial
    Kim, Chae-Yong
    Paek, Sun Ha
    Nam, Do-hyun
    Chang, Jong-Hee
    Hong, Yong-Kil
    Kim, Jeong Hoon
    Kim, Oh Lyong
    Kim, Se-Hyuk
    JOURNAL OF NEURO-ONCOLOGY, 2020, 146 (03) : 399 - 406
  • [45] PHASE 2 OPEN-LABELED STUDY OF ADJUVANT TEMOZOLOMIDE PLUS TUMOR TREATING FIELDS PLUS PEMBROLIZUMAB IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (2-THE-TOP)
    Tran, David
    Warren, Sonisha
    Allen, Anne
    Sampson, Deborah
    Chen, Dongjiang
    Thomas, Nagheme
    Greene, Valerie
    Rahman, Maryam
    Ghiaseddin, Ashley
    NEURO-ONCOLOGY, 2019, 21 : 10 - 10
  • [46] Randomized Phase II trial of Tumor Treating Fields plus radiation therapy plus temozolamide compared to radiation therapy plus temozolomide in patients with newly diagnosed glioblastoma
    Grossman, Rachel
    Limon, Dror
    Bokstein, Felix
    Ben Harosh, Carmit
    Ram, Zvi
    CANCER RESEARCH, 2019, 79 (13)
  • [47] Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma
    Zhu, Jay-Jiguang
    Demireva, Petya
    Kanner, Andrew A.
    Pannullo, Susan
    Mehdorn, Maximilian
    Avgeropoulos, Nicholas
    Salmaggi, Andrea
    Silvani, Antonio
    Goldlust, Samuel
    David, Carlos
    Benouaich-Amiel, Alexandra
    Ram, Zvi
    JOURNAL OF NEURO-ONCOLOGY, 2017, 135 (03) : 545 - 552
  • [48] Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma
    Jay-Jiguang Zhu
    Petya Demireva
    Andrew A. Kanner
    Susan Pannullo
    Maximilian Mehdorn
    Nicholas Avgeropoulos
    Andrea Salmaggi
    Antonio Silvani
    Samuel Goldlust
    Carlos David
    Alexandra Benouaich-Amiel
    Journal of Neuro-Oncology, 2017, 135 : 545 - 552
  • [49] Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients with Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
    Ram, Zvi
    Kim, Chae-Yong
    Hottinger, Andreas F.
    Idbaih, Ahmed
    Nicholas, Garth
    Zhu, Jay-Jiguang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [50] Efficacy Of Tumor Treating Fields (TTFields) In Elderly Patients With Newly Diagnosed Glioblastoma (GBM): Sub-Group Analysis Of The Phase 3 EF-14 Trial
    Ram, Z.
    Zhu, J. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E730 - E731
12345